Prominent investors, such as Hindenburg Research, which is known for betting against companies, had also voiced alarm, accusing Smile Direct Club of “cutting corners” and warning that it would “wind up as a case study in why it’s a bad idea to invest in a company that attempts to fit a complex, dangerous medical process onto a low-cost, high volume assembly line”.
